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Abstract
Background: The three major mechanisms that regulate transcript formation involve the
selection of alternative sites for transcription start (TS), splicing, and polyadenylation. Currently
there are efforts that collect data & annotation individually for each of these variants. It is important
to take an integrated view of these data sets and to derive a data set of alternate transcripts along
with consolidated annotation. We have been developing in the past computational pipelines that
generate value-added data at genome-scale on individual variant types; these include AltSplice on
splicing and AltPAS on polyadenylation. We now extend these pipelines and integrate the resultant
data sets to facilitate an integrated view of the contributions from splicing and polyadenylation in
the formation of transcript variants.
Description: The AltSplice pipeline examines gene-transcript alignments and delineates
alternative splice events and splice patterns; this pipeline is extended as AltTrans to delineate
isoform transcript patterns for each of which both introns/exons and 'terminating' polyA site are
delineated; EST/mRNA sequences that qualify the transcript pattern confirm both the underlying
splicing and polyadenylation. The AltPAS pipeline examines gene-transcript alignments and
delineates all potential polyA sites irrespective of underlying splicing patterns. Resultant polyA sites
from both AltTrans and AltPAS are merged. The generated database reports data on alternative
splicing, alternative polyadenylation and the resultant alternate transcript patterns; the basal data is
annotated for various biological features. The data (named as integrated AltTrans data) generated
for both the organisms of human and mouse is made available through the Alternate Transcript
Diversity web site at http://www.ebi.ac.uk/atd/.
Conclusion: The reported data set presents alternate transcript patterns that are annotated for
both alternative splicing and alternative polyadenylation. Results based on current transcriptome
data indicate that the contribution of alternative splicing is larger than that of alternative
polyadenylation.
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Background
The three major regulatory mechanisms that bring about
formation of alternative transcript patterns from an
expressed gene act at the choice of alternative sites for
transcription start (TS), splicing, and polyadenylation [1-
4]. Use of alternative TS site and/or alternative polyA site
often accompanies alternative splicing [1,4,5]. Currently
there are efforts that collect data & annotation either for
TS variants [1,6-9], or for splice variants [10-24], or for
polyA variants [3,25-28]. These data sets provide a wealth
of value-added annotation (such as tissue specificity, evo-
lutionary conservation, and regulatory motifs). Given that
there is a coupling between the machineries responsible
for transcription initiation, splicing, and polyadenylation
[29-33], it is important to take a coherent & integrated
view of these individual variants and to derive a data set
of alternate transcript patterns along with consolidated
annotation. Previous attempts to integrate variants of
splicing and polyadenylation (as well as of transcript start
sites) introduced new methods for transcript assembly –
notable examples being that of Kim et al [17], Sharov et al
[34], and that of Zavolan et al [4]. General conclusions
from these studies were that (i) a majority of transcription
units showing multiple splice forms contain transcripts in
which the apparent use of an alternative transcription start
(or stop) is accompanied by alternative splicing of the ini-
tial (or terminal) exon; and that (ii) alternative splicing is
a major contributor to transcriptome diversity.
We have been generating data sets on individual variant
types; such data sets include AltSplice [11] and AltPAS
[25]. Both the AltSplice and AltPAS pipelines generate
genome-wide data based on Ensembl [35] gene annota-
tion. The AltSplice pipeline examines gene-transcript
alignments and delineates alternate splice events and
alternate splice patterns; the pipeline characterises the
generated data for various biological features. In the cur-
rent work, we extend the AltSplice pipeline as AltTrans to
annotate the observed splice patterns for terminating
polyA site; the information on the polyA site for a splice
pattern is derived by examining the transcript sequences
that confirm the splice pattern; a splice pattern that could
be annotated for terminating polyA site is termed as tran-
script pattern. The AltPAS pipeline examines gene-tran-
script alignments and identifies potential polyA sites
independently of the underlying splicing patterns; as a
result for a given set of genes, AltPAS derives a larger data
set of polyA sites as compared to AltTrans.
The transcript patterns as derived by the AltTrans pipeline
and the combined list of polyA sites as generated by Alt-
Trans and AltPAS pipelines form the core of the data pre-
sented in this work; these basal data are annotated for
various biological features. The resulting data for human
and mouse is presented to the community in two forms:
(i) through an FTP server as flat file distributions; and (ii)
through user-friendly web query interfaces. Included in
the database are those genes for which at least one tran-
script pattern (annotated both for splicing and terminat-
ing polyA site) was determined.
Construction and content
The different pipelines discussed below are (i) AltSplice
(that delineates splice related data namely, splice sites,
splice patterns and splice events), (ii) AltTrans (that delin-
eates transcript patterns along with annotation for termi-
nating polyA site from AltSplice splice patterns, and (iii)
AltPAS (that delineates all potential polyA sites on the
gene independently of the underlying splicing patterns).
Also discussed are the approaches to integrate the result-
ing data.
Generating splice patterns: the AltSplice pipeline
The methodologies behind the AltSplice pipeline have
been previously reported [11-13] and hence are briefly
mentioned here. The considered gene set is that of the
Ensembl genome annotation project [35]. For each of the
considered genes, the nucleotide sequence of a region that
extends Ensembl-defined gene boundaries by 3000 bases
on either flanking side is extracted as AltSplice gene. Tran-
Derivation of transcript patterns by the AltTrans pipeline from AltSplice splice patternsFigure 1
Derivation of transcript patterns by the AltTrans pipeline 
from AltSplice splice patterns. Each of the gene-transcript 
alignments from AltSplice is examined for the following: (i) 
the alignment shows a 3' dangling end on the EST/mRNA; (ii) 
such a dangling end shows a polyA tail sequence; and (iii) a 
polyA signal is seen on the gene within a maximum distance 
of 40 nts 5' to the cleavage position. Transcripts that show 
these features are grouped in a manner that each class of 
transcripts possesses the same exon/intron organisation and 
the same terminating polyA site. Such derived alternate tran-
script patterns are described as AltTrans transcript patterns. 
Note: Of the three EST's, that are all grouped under one Alt-
Splice splice pattern, the EST3 does not show a "dangling 
end" and hence it is not considered further in the construc-
tion of AltTrans Transcript Patterns. EST1 and EST2 form 
two distinct transcript patterns that differ in terminating 
polyA sites.
EST 1
AltSplice Pattern
EST 2
EST 3
PolyA tailPolyA signal
BMC Bioinformatics 2006, 7:169 http://www.biomedcentral.com/1471-2105/7/169
Page 3 of 13
(page number not for citation purposes)
script (EST and mRNA) sequences as extracted from EMBL
database [36] are used to generate a high quality data set
of gene-transcript alignments showing more than one
high scoring match between gene and transcript
sequences. Any transcript sequence that aligns exclusively
to the flanking regions of a gene is discarded. Further, any
transcript sequence that aligns with more than one gene
or ambiguously with more than one region on a single
gene is discarded. Alignment gaps on gene sequences are
considered as potential introns and their validation as
transcript-confirmed introns is a crucial step in AltSplice
pipeline (see [11-13] for validation procedures). Align-
ment matches on the gene sequence are accepted as a con-
firmed exon if flanked on either side by a confirmed
intron. Thus each transcript sequences that maps to a gene
is described by its exon-intron structure. Transcript
sequences that map to a gene are then grouped into
classes in a manner that the member transcripts from a
class show same exon-intron structure. Longest represent-
ative from each such class denotes a unique splice pattern
for the gene. Overlapping exons and introns from the iso-
form splice patterns are then examined to delineate alter-
native splice events.
Redefinition of AltSplice gene region
An AltSplice gene represents a genomic region containing
(5' flanking 3000 bases + Ensembl gene region + 3' flank-
ing 3000 bases). Once the splice patterns are identified,
we redefine the AltSplice gene region as below:
(i) If no splice pattern is observed extending into flanking
regions, then AltSplice gene is trimmed down to that as
annotated in Ensembl.
Illustration of the relationship between the AltTrans, AltSplice, and AltPAS pipelines/dataFigu e 2
Illustration of the relationship between the AltTrans, AltSplice, and AltPAS pipelines/data.
AltPAS
Detects polyA sites gene-wide 
independent of splicing patterns.
Single-box query (gene 
symbol/keyword/cross 
references
Download of 
AltTrans data
Advanced Query 
Page
Distributed annotation
onto Ensembl system
AltSplice
Makes gene-EST alignments.
Delineates introns/exons, 
splice events, splice patterns, 
peptide variants, etc. 
Annotates for: Splice signals, 
SNP, expression states, human-
mouse conservation, etc.
Passes on the data of splice 
patterns, confirming ESTs, and 
alignments to AltTrans
AltTrans
Examines the ESTs for 
polyA cleavage site and 
signal motif.
Groups the ESTs (that 
could be annotated for 
the above) based on 
splice sites and 
terminating polyA site to 
form Transcript Patterns.
Integration pipeline
Maps AltPAS polyA sites onto 
AltTrans genes. Consolidates the 
(AltTrans & AltPAS) polyA sites. 
Annotates the transcript patterns 
for skipped polyA sites using the 
combined list. 
Integrated AltTrans-AltPAS data
AltSplice :splice patterns/events/introns/exons.
AltTrans: transcript patterns/polyA events/integrated set of polyA sites.
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(ii) If a splice pattern is seen as extending into the 5' flank-
ing region, the genome start location of the splice pattern
forms the 5' bound for AltSplice gene.
(iii) If a splice pattern is seen as extending into the 3'
flanking region, the genome end location of the splice pat-
tern forms the 3' bound of AltSplice gene.
Generating transcript patterns and 'terminating' polyA 
sites from AltSplice splice patterns: the AltTrans pipeline
AltSplice splice patterns and the gene-transcript align-
ments form the basis of AltTrans pipeline that delineates
alternate transcript patterns (see Fig. 1). Each of the gene-
transcript alignments confirming a splice pattern from
AltSplice is examined for the presence of a polyA site that
terminates the transcript sequence. Transcripts displaying
a terminating polyA site are grouped in a manner that
each class of transcript shares the same exon-intron struc-
ture and the same terminating polyA site; representative
from each such class is termed a transcript pattern. These
different steps are as detailed below.
Detecting polyA sites from transcript sequences that confirm
AltSplice patterns. This procedure is of the following three
steps:
(i) Detecting polyA tail and polyA cleavage (PAC) site
Each of the gene-transcript alignments is examined for the
presence of a 3' dangling end on the transcript sequence.
Only those alignments that show 3' dangling ends of
length at least 8 bases are considered further. The tran-
script region -5 to +5 from the end of alignment is exam-
ined for the start of a polyA tail. A polyA tail is defined as
a string of 8 or more adenosines. It is observed that a
higher proportion of the dangling ends are short (5 to 50
bases) and often involve runs of adenosines. While it is
possible that mRNAs can possess long polyA tails, we are
worried about longer dangling ends since their extra
lengths can be results of artefacts in EST sequences or of
genomic 'contaminations' at the 3' ends of the ESTs. We
do want to include transcript patterns involving those
gene-EST alignments with long dangling ends; however,
we want to be sure that such dangling ends contain genu-
ine polyA tails and hence we tightened the requirements
for polyA tail on long dangling ends as below: (length of
dangling end : minimum length of polyA tail) as (= 50 :
8); (>50 & = 100 : 10); (>100 & = 150 : 15); and (>150 :
20). Since it is often the case that a run of adenosines is
interrupted by non-adenosine bases, we allow mis-
matches at up to a maximum of 10% of the positions in
the identified string provided the string still contains the
required number of adenosines (as per the specification
mentioned above); for this purpose, we increase the
search window sequence in advance by 10% to take any
mismatch into account. If more than one polyA tail is
identified starting in the -5 to +5 region, the one with the
highest composition of adenosines is chosen as the
authentic polyA tail. The gene position corresponding to
the start of polyA tail is considered as the cleavage site. As
many as 75% of instances of dangling ends showing a
putative polyA tail are of shorter lengths (<= 50 bases),
8% are of length 50–100 bases; 4% are of length 100–150
bases, and 13% are of length > 200 bases.
(ii) Detecting polyA signal (PAS)
A region on the gene sequence that aligns to the 40 nt
transcript region 5' to the identified cleavage site is
scanned for the presence of one of the 13 variant signals
(namely, AAUAAA, AUUAAA, UAUAAA, AGUAAA,
AAGAAA, AAUAUA, AAUACA, CAUAAA, GAUAAA, AAU-
GAA, UUUAAA, ACUAAA and AAUAGA) reported in the
literature [3] with the criteria that no mismatch is allowed.
For every gene-transcript alignment, all such motifs are
identified. Of multiple matches, a representative motif is
chosen as per the following criteria: (i) one that occurs
within the region of -25 to -15 to the cleavage site is cho-
sen; if multiple such motifs are seen within this region, the
one of highest ranking (as ordered in [3] is chosen; of the
highest ranking ones, the one that is close to the position
of -20 is chosen; (ii) if no signal is seen in the -25 to -15
region, then those identified outside this region are exam-
ined; if multiple signals occur outside the region, the one
of highest ranking located close to the position -20 is cho-
sen. A higher proportion of gene-transcript alignments
with longer dangling ends (that passed the test for pres-
ence of polyA tail) gets removed at this step, when com-
pared to those with shorter dangling ends – we observe
the following relationship between length of dangling
end and proportion of transcripts failing the signal motif
test: < 50 bases : 9%; >50 bases & = 100 bases :14%; >100
bases & = 200 bases :25%; and >200 bases : 33%.
(iii) Grouping nearby cleavage sites and choosing a representative 
cleavage site as polyA site)
At this stage, gene-transcript alignments that do not show
both a cleavage site and a polyadenylation signal are not
considered further. Steps discussed so far identify for every
gene a set of cleavage sites along with polyA signals. It is
often the case that some of the identified cleavage sites are
close to one another. Given that a polyA site can harbour
multiple cleavage sites [3,25,37] and also that errors in
sequences can lead to small differences in the locations of
identified cleavage sites, it is possible that the adjacent
sites are not distinct polyA sites. Thus it is essential to have
a method in place to identify which of the close by sites
can be chosen as an authentic polyA site. The identified
cleavage sites are classified onto groups such that a mem-
ber of a group differs from its immediate 5' neighbour by
a maximum of 5 bases; the 5' most site from each such
group is then chosen as the representative polyA site for
BMC Bioinformatics 2006, 7:169 http://www.biomedcentral.com/1471-2105/7/169
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that group of transcripts. Each member gene-transcript
alignment of the group is annotated by such a representa-
tive polyA site and its associated signal motif.
Forming the transcript pattern classes
At this stage, for every gene a set of gene-transcript
sequences with known exon-intron structure and termi-
nating polyA site is available. The transcript sequences are
then grouped into classes in such a manner that members
of a class show same exon-intron structure and same ter-
minal polyA site. The longest representative member of
each such class is termed as a "Transcript Pattern".
Identifying all potential polyA sites (independent of 
underlying splicing patterns): the AltPAS pipeline
The list of polyA sites as identified by AltTrans pipeline is
by no means comprehensive for the reason that AltTrans
examines only those gene-transcript alignments confirm-
ing AltSplice splice patterns. AltPAS is a generic pipeline
that identifies all potential polyA sites irrespective of
whether the examined gene-transcript alignments reveal
any underlying splicing pattern or not. The methodology
used is described in [25] and is briefly discussed below.
EST sequences and full-length cDNA sequences are
obtained from transcript resources such as dbEST [38], H-
Inv [39], and FANTOM [40]. Of the EST sequences, only
those that are annotated as from the 3' end of gene are
retained. Trailing polyA or polyT sequences of 5 nt or
more are removed from the EST sequences. Both the 3'
EST and cDNA sequences (termed transcript sequences)
are aligned to the repeat-masked genome using the
MegaBlast program [41]. High scoring matches are
retained for further analysis. The matches are then clus-
tered in a manner that transcript members from a cluster
have their end positions located within a range of 10
nucleotides from each other. Each cluster is then analyzed
using a sliding 10-nt window to locate the most likely
cleavage site, defined as the position where the window
contains the ends of most transcripts. Alignment hits with
more than 5 unmatched positions at cleavage site are dis-
carded. Cleavage sites that are flanked by A-rich region (at
least 9 out of 10 nt positions are adenosines) in the 50 nt
downstream genomic sequence, and those that do not
contain one of the known polyA signals in the 30 nt
upstream region are discarded. Of the remaining cleavage
sites, only those that are supported by at least two tran-
script sequences are retained as potential polyA sites. The
polyA sites, thus identified, are denoted using genome
coordinates. Assignment of the detected polyA sites to
Ensembl genes is carried out as below: A polyA site is
assigned to the Ensembl gene to which the site's genome
location can be mapped; if the genome location of a
polyA site does not map to any annotated gene, it is
Table 1: Statistics on Transcript Pattern Variant Data presented in this work.
Human Mouse
Genes 7669 5862
Splice patterns (& average number per gene) 41201 (5.4) 27132 (4.6)
Transcript patterns (& average number per gene) 12559 (1.6) 7755 (1.3)
PolyA sites as detected by AltTrans pipeline1 (& average number per gene) 10221 (1.3) 6976 (1.19)
AltTrans polyA sites that are "skipped" 2468 1113
ATD PolyA sites as detected by AltTrans and AltPAS2 pipelines (& average number per gene) 17104 (2.2) 9451 (1.61)
ATD polyA sites that are "skipped" 5459 2214
Genes showing splice events (as seen among the splice patterns) 5672 (74%) 3825 (65%)
Genes showing multiple polyA sites (considering the polyA sites from both AltTrans and AltPAS)3 4603 (60%) 2456 (42%)
Genes showing both splice events and multiple polyA sites (considering the polyA sites from both 
AltTrans and AltPAS)
3523 (46%) 1718 (29%)
Genes showing multiple polyA sites (considering only the AltTrans polyA sites)4 2053 (27%) 1026 (18%)
Genes showing both splice events and polyA events (considering only the AltTrans polyA sites) 1679 (22%) 736 (13%)
Genes showing >= 2 Splice Patterns 6859 4989
Genes showing >= 2 Transcript patterns 3179 1548
EST/mRNA sequences confirming Splice Patterns 837828 726916
EST/mRNA sequences confirming Transcript Patterns 38731 18045
1:AltTrans pipeline requires for a transcript pattern that the underlying splicing and the terminating polyA site are confirmed by the same set of 
EST./mRNA sequences.
2:AltPAS pipeline identifies polyA sites independent of the underlying splicing pattern.
3:A gene is considered as undergoing alternative polyadenylation if it multiple polyA sites (from the merged list of AltTrans and AltPAS polyA sites) 
are seen mapped to the gene.
4:Consideration of only the AltTrans polyA sites gives a conservative estimate for the extent of alternative polyadenylation. AltTrans polyA sites 
differ from AltPAS sites in the manner they are detected; AltTrans polyA sites are confirmed by the same set of EST/mRNA sequences that confirm 
the splice structure of transcript pattern.
BMC Bioinformatics 2006, 7:169 http://www.biomedcentral.com/1471-2105/7/169
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Distribution of spacing between polyA cleavage (PAC) site and polyA signal (PAS) in human transcript patterns from AltTransFigure 3
Distribution of spacing between polyA cleavage (PAC) site and polyA signal (PAS) in human transcript patterns from AltTrans. 
The bottom inset uses the data set of heterogeneous polyA sites; the top inset uses the data set of representative polyA sites 
(Nearby heterogeneous polyA sites are grouped and a representative polyA site is chosen – see text for methods).
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assigned to the nearest 5' gene, provided that the distance
to gene is less than 3000 bases.
Integrating polyA sites from the AltPAS and AltTrans 
pipelines
Of the polyA sites identified by the AltPAS pipeline, con-
sidered further are only those that can be mapped within
the bounds of AltTrans genes. PolyA sites identified by
both pipelines are merged. Adjacent polyA sites are then
grouped and a representative polyA site is chosen from
each group. The procedure adopted for the grouping proc-
ess is same as that used for grouping AltTrans polyA sites
(discussed in earlier sections) with the following varia-
tion. If a group contains sites from both AltTrans and Alt-
PAS, the 5' most AltTrans site is chosen as the
representative. Such a set of representative polyA sites is
subsequently used to annotate a gene with all potential
polyA sites, and to annotate a transcript pattern for poten-
tially "skipped" polyA sites. It is to be noted that a tran-
script pattern in the data set always ends with an AltTrans
polyA site as the terminating polyA site.
Discussion
We have been providing to the community an alternative
splicing database (ASD) that integrates data from a com-
putational pipeline (AltSplice) and from a manual cura-
tion effort (AEdb); such a database specializes on splicing
events and their characteristics (see [11,12]). AltTrans,
described in this manuscript, is an extension of AltSplice.
It considers the splicing patterns as detected by AltSplice
and examines the transcript sequences (that confirm each
of the splicing patterns) for polyA sites. The transcript
sequences thus annotated for both splicing pattern and
polyA site are regrouped to form distinct transcript pat-
Examples of PolyA table and transcript pattern tableFigure 4
Examples of PolyA table and transcript pattern table. Locations of the polyA site and signal are as on the gene. Status of the 
polyA site refers to whether the site is identified by the AltTrans or AltPAS pipeline. Entry in the last column is hyperlinked to 
pages listing detailed information on the confirming transcript sequences.
BMC Bioinformatics 2006, 7:169 http://www.biomedcentral.com/1471-2105/7/169
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terns. PolyA sites detected by AltPAS, an independent
computational procedure, are also mapped to the Alt-
Trans genes set. Transcripts produced by the AltTrans
pipeline are presented as part of the ATD (Alternate Tran-
script Diversity) database. Figure 2 illustrates the relation-
ship between AltSplice, AltTrans, and AltPAS pipelines/
data. AltTrans is an important resource that elucidates the
transcript complexity owing to alternative splicing and
alternative polyadenylation. AltTrans will be further
extended in future to provide information on transcript
start as well. The possible applications include derivation
of SAGE tags, derivation of exon junction probes for splice
arrays, and primers for transcript-specific RT-PCR experi-
ments.
Data sets of transcript patterns were derived for both
human and mouse. Statistics on the generated data is pre-
sented in Table 1 and is discussed in the following sec-
tions.
Human data set
The data set of human transcript patterns contains 7669
gene entries for each of which is derived at least one pat-
tern that is fully annotated for both splicing and terminat-
ing polyA site. The total number of transcript patterns is
12559 (at an average of 1.6 per gene) encoded by 10221
terminating polyA sites. In 3179 of the 7669 AltTrans
genes, two or more alternate transcript patterns could be
observed. Inclusion of AltPAS polyA sites annotated an
additional 6883 polyA sites raising the number of polyA
sites mapped to 17104.
Mouse data set
The data set of mouse transcript patterns contains 5862
gene entries. The total number of transcript patterns is
7755 (at an average of 1.3 per gene) encoded by 6976 ter-
minating polyA sites. In 1548 of the 5862 AltTrans genes,
two or more alternate transcript patterns could be
observed. Inclusion of AltPAS polyA sites annotated an
additional 2475 polyA sites raising the number of polyA
sites mapped to 9451.
Extent of alternative splicing versus alternative 
polyadenylation
Examination of data presented in Table 1 indicates that
the proportion of human and mouse genes undergoing
alternative splicing (at 74% and 65%, respectively) is
higher than the proportion of genes undergoing alterna-
tive polyadenylation (at 60% and 42%, respectively). The
above estimates are in agreement with those reported in
literature – see [42] for estimate on alternative splicing
and [3,25] on alternative polyadenylation. It is also seen
that one in two human genes (close to one in three mouse
genes) may undergo both alternative splicing and alterna-
tive polyadenylation. Considering only the polyA sites
detected by the AltTrans pipeline (which requires that
transcripts that confirm a polyA site also confirm the splic-
ing of the transcript pattern) reveals a conservative esti-
mate for extent of alternative polyadenylation at 27% for
human and 18% for mouse.
Limitations with regard to low number of reported 
transcript patterns
There is a large discrepancy in the numbers for observed
splice patterns and observed transcript patterns. While the
average number of observed splice patterns per human
gene is 5.4, the average number of observed transcript pat-
terns is a mere 1.6 (the corresponding numbers in the case
of mouse data are 4.6 and 1.3). This discrepancy is due to
the fact that for an EST/mRNA sequence to confirm a tran-
script pattern, it is required that the sequence confirms
both the splicing and terminating polyA site. EST
sequences do not often cover simultaneously both the
internal and 3' regions of the gene – this is reflected in the
observed numbers (see Table 1) for the EST/mRNA
sequences that confirm splice patterns and transcript pat-
terns (e.g. of the 837828 EST/mRNA sequences that con-
firm the human splice patterns, a mere 38731 contain
enough information to confirm transcript pattern). As a
result, the number of identified polyA sites by the AltTrans
pipeline is expected to be reduced AltTrans detected
10221 polyA sites in 7669 human genes. AltPAS, that
detects polyA sites independently of the underlying splic-
ing process, mapped a further 6883 polyA sites to the
same set of 7669 human genes. It is possible to increase
the number of transcript patterns by using the AltPAS
polyA sites as well to annotate the gene-transcript align-
ment for 'terminating' polyA site; however, we have
restrained from doing this for the reason that it is our
intention to provide a high quality set of transcript pat-
terns, individual structural elements of which are con-
firmed by same set of EST/mRNA sequences.
Heterogeneity of cleavage sites
It is known that a polyA site can harbour multiple cleav-
age sites and that polyadenylation can be an imperfect
process [3,25,37,43]. However, it is possible that the
small differences in the locations of multiple cleavage
sites can be due to artefacts in EST sequences. The method
that we adopted to select a polyA site from multiple cleav-
age sites involve grouping the sites in a manner that each
member of the group differ from its 5' neighbour by a
maximum of 5 bases. Upon examination of the distance
between the locations of the 5'-most and 3'-most member
sites in every group, it is seen that such an 'inner group dis-
tance' is non-zero only in 25% instances of the observed
groups. An inner group distance of = 5 bases is seen only
in 8% of instances. It may be possible that the grouping
process can be refined further. However, it is often seen
that the member cleavage sites of a group have the signal
BMC Bioinformatics 2006, 7:169 http://www.biomedcentral.com/1471-2105/7/169
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motifs identified at same gene position; and that the dis-
tribution of distance between the representative cleavage
site and polyA signal (Fig. 3) show the expected normal
distribution (while the distribution for the raw members
show a bi-modal distribution). It is possible that the 3'
ends of mRNAs are marked, in addition to polyA signal
and polyA tail, by regions with distinct nucleotide compo-
sitional biases [43]. It is expected that incorporation of
such signatures and statistical approaches (such as the one
implemented in [43]) will lead to improvements in our
above-discussed methods.
Core data and derived annotations
The core of the generated data comprises the following
components: (i) Genes and transcript data; (ii) introns/
exons, polyA sites; (iii) isoform splice patterns, isoform
transcript patterns, isoform peptide sequences; and (iii)
alternative splice events, alternative polyadenylation
Example of splice pattern table and splice event tableFigure 5
Example of splice pattern table and splice event table. Locations of exons are as on the gene.Inset A: Entry in column 1 is 
hyperlinked to a page listing the sequence of the splice pattern. Entry in column 2 gives the coding start & end positions on the 
gene and the length of the translated peptide sequence and is hyperlinked to a page listing the peptide sequence. Entry in col-
umn 3 lists the structure of the splice pattern as a string of exons. Entry in column 4 is hyperlinked to pages listing detailed 
information on the confirming transcript sequences. Entry in column 5 is hyperlinked to pages listing EST/mRNA sequences. 
Entry in column 6 is hyperlinked to pages listing allele specificity of the splice pattern. Inset B: Column 1 lists the exons 
involved in the event (in this example cassette exon event). Column 2 indicates whether the event involves modifications in the 
flanking exons as well; entries are hyperlinked to pages listing detailed information on the event. Column 3 indicates the identi-
fier of the orthologous gene and the coordinates of the exon orthologous to the one presented in column1; the entry is hyper-
linked to the orthologous gene entry.
A
B
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events. Various value-added annotations are also gener-
ated, some of which are as described below.
Preservation of splice events across species
An important part of our pipeline is to generate evolution-
ary profiles of gene expression patterns. Methods based
on the identification of conserved introns/exons and of
conserved splice events [44] have been standardized to
delineate pairs of human and mouse genes that are orthol-
ogous to each other. This data enables studies on evolu-
tionary profiles of expression patterns.
Association with data on genetic variation (SNP, single nucleotide 
polymorphism)
We have developed methods (as documented in the ATD
web pages) to delineate the allele specificity of observed
alternative splice patterns.
Derivation of peptide sequences coded by isoform splices patterns
We have developed methods to delineate the amino acid
sequence of the protein sequences encoded by the isoform
splice patterns.
Inset A: Example of transcript pattern viewFigure 6
Inset A: Example of transcript pattern view. Exons are indicated by boxes and introns by lines. Exons/introns that are variants 
are indicated in blue colour. Browsing the cursor over various elements of a pattern displays pop-up's giving detailed informa-
tion on the elements. The displayed pop-up in this example shows information on the polyA sites that maps to the alternate 
transcript pattern AT2; of these two polyA sites, the first one (located at gene position 9317) terminates the transcript pattern 
while the second one (located at gene position 9189) is skipped and is not used as a terminating polyA in the formation of this 
pattern. Inset B: Example snapshot of a portion of Ensembl gene display page to illustrate the integration of the AltTrans data 
in Ensembl genome annotation project.
A
B
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Data access and query interfaces
The data was generated as part of the European Project on
Alternate Transcript Diversity (ATD). The data can be
downloaded as flat files or queried through web inter-
faces. The web interface provides single-box query (where
a user can search the database against a keyword or gene
symbol or database cross-references) or a detailed query
page that searches simultaneously both the human and
mouse data or a query page that provides advanced
searches to either human or mouse data.
Genes can be queried by chromosomal location, gene
names and synonyms, protein keywords, and database
cross-references [such as EMBL and UniProt accession
numbers [36,45], HUGO gene symbols [46], Gene Ontol-
ogy identifiers [47] and protein identifiers], types of splice
events, types of polyA signal, number of observed polyA
sites, and types of variations among isoform transcript
patterns (a pair of isoform transcript patterns may differ
only in splicing or only in polyadenylation or in both).
Queries can be selectively restricted to specific sets of gene
entries, such as set of human-mouse orthologous gene
pairs or set of gene entries for which data on isoform pep-
tide sequences is available.
Data presentation (textual & graphical displays) and 
integration
An output page resulting from a query to the database lists
for every gene entry all the available database cross-refer-
ences; an important aspect being hyperlinks to ortholo-
gous genes from other organisms (currently implemented
for human and mouse).
Observed PolyA sites and transcript patterns are presented
in tabular forms (Fig. 4). Typical information on a polyA
site includes gene locations of the cleavage site and of the
polyA signal, the signal sequence, and hyperlink to a page
that lists the EST/mRNA sequences that confirm the polyA
site. Typical information on a transcript pattern includes
exon-intron structure of the pattern, locations of the 'ter-
minating' polyA site (along with that of the polyA signal),
polyA sites that are skipped in the formation of the pat-
tern, hyperlinks to pages that list EST/mRNA sequences
that confirm the pattern.
Observed introns & exons are listed, and are hyperlinked
to a page presenting data on EST/mRNA sequences that
confirm these features. Observed splice patterns and
events are listed (Fig. 5) and are hyperlinked to pages that
list information on confirming EST/mRNA sequences.
Typical information on a splice pattern includes hyper-
links to pages listing the coding information & sequences
of the isoform peptides, detailed exon-intron structures &
sequences of the isoform splice sequences, or listing the
observed SNP positions and allele specificity. Typical
information on a splice event includes information on the
type of event, exon/intron feature that undergoes alterna-
tive splicing, hyperlink to a page giving details on the
exon/intron features involved in the alternative splicing,
or hyperlinks to the event in an orthologous gene from
another species.
Pattern viewers that give visual presentation of the
observed isoform splice pattern structures and of the
observed transcript pattern structures are provided. An
example of transcript pattern view is presented in Fig. 6A.
Each element of the pattern such as exon/intron/polyA
site and the pattern as such is hyperlinked to pages giving
detailed information (including nucleotide sequence, and
detected signals).
The AltTrans data has been integrated with the Ensembl
genome annotation project and is visible as DAS (Distrib-
uted Annotation System) tracks from the gene view and
contigview pages in Ensembl genome browser (Fig. 6B).
Conclusion
We present here an integrated data set of transcript-con-
firmed introns/exons, polyA sites, isoform splice patterns,
isoform transcript sequences, isoform peptide sequences,
alternative splice events, and alternative polyadenylation
events. The data is presented for both mouse and human.
Future work will aim to annotate the alternate transcripts
for transcription start sites and their variants. In its future
extension, this work should ultimately present high qual-
ity data on full-length transcript patterns annotated for
transcription start site, splice sites, and polyadenylation
sites; with each of these individual signals annotated for
variations and for biological characteristics such as regula-
tory motifs and evolutionary profile.
Availability and requirements
Release 1 of the integrated AltTrans data, presented in this
manuscript, is available from http://www.ebi.ac.uk/atd.
Enquiries on accessing the data can be mailed to asd-
ebi@ebi.ac.uk.
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